Cargando…
Liver injury induced by COVID 19 treatment – what do we know?
The severity of coronavirus disease 2019 (COVID-19) may be correlated with the risk of liver injury development. An increasing number of studies indicate that degrees of hepatotoxicity have been associated with using some medications in the management of COVID-19 patients. However, limited studies h...
Autores principales: | Saha, Lekha, Vij, Soumya, Rawat, Kajal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753058/ https://www.ncbi.nlm.nih.gov/pubmed/36533104 http://dx.doi.org/10.3748/wjg.v28.i45.6314 |
Ejemplares similares
-
Appendiceal phlegmon in adults: Do we know how to manage it yet?
por: Panahi, Pedram, et al.
Publicado: (2020) -
Liver injury in COVID-19: What do we know now?
por: Yang, Hua-Yu, et al.
Publicado: (2020) -
Quasicrystals: What do we know? What do we want to know? What can we know?
por: Steurer, Walter
Publicado: (2018) -
What do we know and when do we know it?
por: Nicholls, Anthony
Publicado: (2008) -
Presbyopia: What We Do Know and What We Do Not Know in 2022
por: Grzybowski, Andrzej, et al.
Publicado: (2023)